Why The Future Of Big Pharma Is Beyond Illness | Hall & Partners

Why the future of big pharma is beyond illness


There is little question that the current US healthcare system is unsustainable. With its traditional focus on sickness (vs wellness), overwhelming paperwork and high-cost care, even middle-class insured consumers can find themselves one health crisis away from bankruptcy, while doctors struggle with burnout and bureaucracy.

To stay sustainable, we in the healthcare industry need to lean into the holistic and preventative wellness approaches being embraced by brands, health systems and politicians alike. Brands that interact with a patient only once they become sick will soon be left behind. At TBWA, we’re helping our clients navigate this shifting landscape and champion disruptive new approaches that will reshape their categories forever.

In 2016, US healthcare costs for chronic diseases totaled $1.1tn. Nearly 900,000 individuals in the US die annually from heart disease, cancer, chronic respiratory disease, stroke and injury. The Centers for Disease Control and Prevention estimates that 20–40% of these deaths are preventable, largely through behavior modification and a focus on healthier lifestyles.

Emerging trends in wellness are shifting the lens through which we view illness. Rather than engaging with a patient once they become ill, these approaches are taking a more holistic view – interacting with consumers throughout their lives in order to prevent catastrophic and emergency events in the first place.

Hall & Partners Social Determinants of Health 1024x1024 1

Social determinants of health

This trend has been echoed in social movements, advancements in health tech and political will in legislation, which has implications for both small businesses and large industry players. Nearly 60% of an individual’s life expectancy is determined outside of a doctor’s office. An understanding of the social determinants of health (SDoH)4 – the social, economic and environmental factors that contribute to an individual’s health outcomes – has become less of an academic exercise and more of a guiding principle for those working in the healthcare industry.

Brands and healthcare providers are taking a variety of approaches to creating sustainable models of care: harnessing the power of technology; organizational design and restructuring; and leaning into more non-traditional business models and unique partnerships.

Brands have an exciting opportunity to become partners throughout consumers’ lives

CVS Health’s platform, Destination: Health, allows healthcare workers to make electronic referrals for non-clinical services such as rides and meals that address SDoH within their clinical workflow. It also hosts an analytics tool that enables businesses and insurers – in this case, Aetna – to better understand the connection between SDoH and productivity, ultimately allowing for possible adjustments to policies and benefits that most support employees. Key partnerships and collaborations are allowing companies to harness the power of innovation and ‘start-up’ approaches (and funding) to disrupt markets in order to appeal to a wider audience.

There are also examples of more low-tech organizational restructuring that have the same effect. TBWA works with WellStar Health System which is upending the traditional definition of primary care by engaging with customers in all areas of their lives and seeking to streamline the access-to-care processes. Wellstar believes in ‘a life well-lived’ and seeks to emphasize the importance of not just sick care, but comprehensive wellness. Their ‘health parks’ serve as a one-stop shop for physician visits, diagnostics, urgent care, pharmacy services, sleep studies and more. Vice President of Consumer Engagement, Leanne Cook, emphasizes, “As part of healthcare today, it’s important to support the wellness of our entire community in multiple ways. If we demonstrate healthy habits, it encourages the people who live in our entire area to flourish.”Hall & Partners %C2%A9 Xeris Pharmaceuticals Inc.

© Xeris Pharmaceuticals, Inc.

Of course, not all illnesses can be avoided by addressing SDoH and following a preventative care approach. Brands can embrace sustainable approaches in the design of treatments and medications that reduce catastrophic cost to both consumers and the system. A great example is Xeris’ ground-breaking Gvoke Pre-Filled Syringe™ which delivers pre-mixed, pre-measured liquid glucagon, indicated for severe hypoglycaemia in adults and kids with diabetes. “Innovations in this space,” says Rebecca Bechily, Xeris’ Director of Marketing, “may mean more people – patients and caregivers – could have the confidence to address hypoglycaemic events as they happen and potentially reduce associated healthcare resource utilization.”

The common denominator in much of what we’re seeing is an on-demand, bespoke approach to healthcare – one that strives to meet consumers often before they would seek care themselves and addresses the underlying causes of disease with as much rigor as the disease itself. Brands have an exciting opportunity to reach beyond talking to patients strictly in the context of their treatment, and to become partners throughout consumers’ lives. In the era of die-versification – where brands either ‘diversify traditional offerings or die’ – this shift has become less about innovation. It’s now vital for brand sustainability.

Hannah Wesley
Hannah Wesley
TBWA / HealthCollective

Check out more Big Thinking Articles

Gen z

‘Zoomers’ call on businesses to be kinder to staff, more transparent and respectful of their privacy

5 ways UK marketers can combat the HFSS ad ban

Travel and tourism are struggling right now, but a new future for hospitality beckons

Conscious Health webinar highlights

We made the GRIT ‘Top 50 Most Innovative Companies’

Are behaviour change strategies useful for tackling health inequality?

The key to creating better habits? Temptation bundling

PharmaExec: Hall & Partners on purposeful partnerships for a post-COVID era

Research Live: Vanella Jackson helps form MRS Disability Group

WARC: Hall & Partners explain how pharma can keep building trust

About Hall & Partners

Hall & Partners is a global insight agency that specialises in quantitative and qualitative market research, data analytics and strategic consultancy. 

We provide brand performance tracking, customer segmentations, customer and brand experience, predictive modelling, insight engagement platforms, as well as communications and advertising strategy. This is in addition to our award-winning insight platform, The Hub.

Our global team help brands, businesses and organisations in the Americas, Africa, Asia, Europe, and the Middle East inspire growth. Together, we utilise over three decades of insight expertise to solve the toughest branding, marketing, communications, and innovation challenges for our clients.

Hall & Partners is a part of Omnicom’s Communications Consultancy Network.

Subscribe to our newsletter

By submitting this form you are opting in to receive occasional brand, marketing and communications insights from Hall & Partners.

© 2021 Hall & Partners. This website is powered by 100% renewable energy. All rights reserved.

Website developed by Digital Berry Ltd

Signup for our Newsletter

A monthly newsletter bursting with thinking on how to grow your brand: from in-depth analysis to practical advice. Sign-up for the latest industry perspectives, insight reports, free-to-attend webinars, and exclusive events.

By submitting this form you are opting in to receive occasional brand, marketing and communications insights from Hall & Partners.